CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
ModiQuest (CRO) focus is on generation of recombinant monoclonal antibodies (animal, human). The company use antigen specific B-cell selection combined with efficient hybridoma generation or direct antibody cDNA cloning from selected B-cells. MQR off...Show all
Company (Alive / Active)
Phone:
Schoutstraat 58
6525 XV
Netherlands
| Total Funding | Date of Last Funding | |
|---|---|---|
| ModiQuest | $0M | Oct 10, 2019 |
| See all 12 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|---|---|---|
| PPM Oost | Venture Capital | Arnhem, Netherlands | Other Investors |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Anti-inflammatory agents | Jun 04, 2009 | Aug 01, 2017 | Patent |
| Plexin d1 as a target for tumor diagnosis and therapy | Jul 03, 2012 | Aug 23, 2016 | Patent |
| Anti-inflammatory agents | Dec 10, 2010 | Aug 18, 2015 | Patent |
| Peptidylarginine deiminase (pad) inhibitors | Dec 10, 2010 | Mar 26, 2013 | Patent |
| Anti-inflammatory agents | Jun 22, 2017 | Application |
